Literature DB >> 2684399

Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas.

N H Bander1, C L Finstad, C Cordon-Cardo, R D Ramsawak, E D Vaughan, W F Whitmore, H F Oettgen, M R Melamed, L J Old.   

Abstract

Murine monoclonal antibody (mAb) F31 detects a heat-stable antigen (URO-8) found in the acidic lipid fraction of renal cancer cell extracts. Serological analysis of mAb F31 reactivity was assayed on 176 human cell lines. mAb F31 reacted with 38 of 45 renal cancers, a subpopulation of cells in primary cultures of normal renal epithelia, and two of 13 colon, two of 15 lung, and four of five ovarian cancers. No other epithelial, hematopoietic, or neuroectodermal cell lines tested were reactive. Immunofluorescence and immunoperoxidase analyses of fresh frozen tissue sections revealed mAb F31 reactivity in kidney, gastrointestinal tract, biliary canaliculi, bronchial epithelium, and skin. Within the kidney, mAb F31 immunoreactivity was confined to the straight portion of the proximal tubule. A panel composed of previously characterized mAbs as well as mAb F31 defines the antigenic phenotype of proximal convoluted tubular cells as URO-2+/URO-3+/URO-4+/URO-10+/URO-8-/URO-5-; proximal straight tubular cells as URO-2+/URO-3+/URO-4+/URO-10-/URO-8+/URO-5-; and cells of the descending thin limb of Henle as URO-2-/URO-3+ or -/URO-4+/URO-10-/URO-8-/URO-5+. While adult proximal tubular cells demonstrated reciprocal expression of URO-8 and URO-10, fetal kidney proximal tubule progenitor cells coexpressed both antigens (URO-10+/URO-8+). Fifty renal cancer specimens were typed with these antibodies. Fourteen cases were URO-10+/URO-8-, ten cases were URO-10-/URO-8+, and 25 cases expressed both antigens (URO-10+/URO-8+). These phenotypes are consistent with derivation of these particular subsets from the proximal convoluted tubule, the pars recta, or a proximal tubule progenitor cell, respectively. Only one specimen failed to express either URO-8 or URO-10.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684399

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.

Authors:  Amy E Krambeck; R Houston Thompson; Haidong Dong; Christine M Lohse; Eugene S Park; Susan M Kuntz; Bradley C Leibovich; Michael L Blute; John C Cheville; Eugene D Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-23       Impact factor: 11.205

2.  The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney.

Authors:  Philipp Lechler; Xiaoqing Wu; Wanja Bernhardt; Valentina Campean; Susanne Gastiger; Thomas Hackenbeck; Bernd Klanke; Alexander Weidemann; Christina Warnecke; Kerstin Amann; Dirk Engehausen; Carsten Willam; Kai-Uwe Eckardt; Franz Rödel; Michael Sean Wiesener
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

3.  Radiolabeled monoclonal antibody G250 in renal-cell carcinoma.

Authors:  E Oosterwijk; F M Debruyne
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

4.  Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A.

Authors:  D M Nanus; D Engelstein; G A Gastl; L Gluck; M J Vidal; M Morrison; C L Finstad; N H Bander; A P Albino
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

5.  Expression of cell adhesion molecules in an established and characterized new human renal cell cancer line, CCF-RC7.

Authors:  F Steinbach; J Alexander; K Tanabe; R Troy; M G Edinger; R R Tubbs; J T McMahon; A C Novick; E A Klein
Journal:  Urol Res       Date:  1995

6.  The Relationship between B7-H4 Expression and Clinicopathological Characteristics in Clinical Stage T1 Conventional Renal Cell Carcinoma.

Authors:  Suk Gun Jung; Kyung Un Choi; Sang Don Lee; Zeong Zoo Lee; Moon Kee Chung
Journal:  Korean J Urol       Date:  2011-02-19

7.  Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice.

Authors:  I Gresser; C Carnaud; C Maury; A Sala; P Eid; D Woodrow; M T Maunoury; F Belardelli
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

Review 8.  Radiolabeled antibodies in renal cell carcinoma.

Authors:  Alexander B Stillebroer; Egbert Oosterwijk; Wim J G Oyen; Peter F A Mulders; Otto C Boerman
Journal:  Cancer Imaging       Date:  2007-11-19       Impact factor: 3.909

Review 9.  Antibody therapy in renal cell carcinoma.

Authors:  Egbert Oosterwijk; Otto C Boerman; Wim J C Oyen; Lloyd J Old; Peter F A Mulders
Journal:  World J Urol       Date:  2008-02-01       Impact factor: 4.226

10.  Expressions of ABCG2, CD133, and podoplanin in salivary adenoid cystic carcinoma.

Authors:  Wuwei Li; Ryo Tamamura; Bo Wang; Qigui Liu; Han Liu; Tingjiao Liu; Naoki Katase; Jing Xiao; Hitoshi Nagatsuka
Journal:  Biomed Res Int       Date:  2014-04-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.